Search

Author/Creator Reichmann, William

2. Comparative efficacy of brigatinib versus ceritinib and alectinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-small cell lung cancer. (3rd April 2019)

Authors:
Reckamp, Karen; Lin, Huamao M.; Huang, Joice; Proskorovsky, Irina; Reichmann, William; Krotneva, Stanimira; Kerstein, David; Huang, Hui; Lee, Joseph
Journal:
Current medical research and opinion
Issue:
Volume 35:Number 4(2019)
Page Start:
569
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States. (2nd July 2016)

Authors:
Sandborn, William J.; Sakuraba, Atsushi; Wang, Anthony; Macaulay, Dendy; Reichmann, William; Wang, Song; Chao, Jingdong; Skup, Martha
Journal:
Current medical research and opinion
Issue:
Volume 32:Number 7(2016:Jul.)
Page Start:
1233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma. Issue 1 (25th November 2020)

Authors:
Richardson, Paul G.; Jagannath, Sundar; Chari, Ajai; Vogl, Dan T.; Dimopoulos, Meletios A.; Moreau, Philippe; Dingli, David; Wei, Lee‐Jen; Richter, Joshua; Biran, Noa; Siegel, David; Reichmann, William; Li, Lingling; Tang, Shijie; Saint‐Martin, Jean‐Richard; Joshi, Anita; Kauffman, Michael; Shah,...
Journal:
EJHaem
Issue:
Volume 2:Issue 1(2021)
Page Start:
48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗